US 8710075
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/4365A61P
Quick answer
US patent 8710075 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K31/4365, A61P, A61P11/00, A61P13/12